Drug Type Small molecule drug |
Synonyms Fibrostat, Putrescine |
Target |
Action inhibitors |
Mechanism TGM2 inhibitors(Protein-glutamine gamma-glutamyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC4H12N2 |
InChIKeyKIDHWZJUCRJVML-UHFFFAOYSA-N |
CAS Registry110-60-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Putrescine dihydrochloride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | South Korea | 02 Jan 2024 | |
Cicatrix, Hypertrophic | Preclinical | - | - | |
Cicatrix, Hypertrophic | Preclinical | United States | - | - |
Cicatrix, Hypertrophic | Preclinical | - | - | |
Cicatrix, Hypertrophic | Preclinical | Canada | - | - |